Biogen validates anti-tau approach at AAIC, psychedelics full speed ahead, ATTR-CM shakeup

Biogen’s new data, presented at the Alzheimer's Association International Conference, supports a tau-focused approach to the intractable neurodegenerative disease; psychedelics are back in the news…